New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 28, 2014
11:34 EDTVIVOMeridian receives Canadian licenses for two illumigene platforms
Meridian Bioscience announced that it has received medical device license approval from Health Canada to market two additional assays for use on their illumigene molecular diagnostic platform. With the addition of illumigene Mycoplasma and illumigene Pertussis, Meridian continues to expand its position in the Canadian market by providing innovative testing solutions that meet the needs of the clinical laboratory and drive improvements in patient care.
News For VIVO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2015
07:34 EDTVIVOMeridian Bioscience still sees FY15 EPS 85c-91c, consensus 86c
Subscribe for More Information
07:34 EDTVIVOMeridian Bioscience reaffirms FY15 guidance
07:33 EDTVIVOMeridian Bioscience reports Q2 EPS 24c, consensus 24c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use